📚 Clinical Immunology

Full Title: *Clinical Immunology* Publisher: Elsevier ISSN: 1521-6616 Impact Factor (2024 est.): ~4.0 Scope: Immunopathology, autoimmunity, immune tolerance, infectious immunology, immune-based therapies

* Broad thematic reach across translational and clinical immunology: from autoimmunity to immune-oncology * Publishes both basic science and clinical application studies — often bridging the gap effectively * Reputable editorial board and robust peer review process * Frequently cited in autoimmune disease and infection-related immunology literature * Accepts mechanistic, biomarker, and immunotherapeutic studies

* Articles often lean toward descriptive data with limited mechanistic depth — especially in immunohistochemistry-heavy or serologic correlation papers * Tendency to publish associative findings without definitive causal frameworks — leading to speculative conclusions * Impact Factor remains modest compared to journals like *The Journal of Clinical Investigation* or *Nature Immunology* * Inconsistent editorial quality in some observational studies and case series

While *Clinical Immunology* is not neurology-focused, it’s a valuable resource when exploring:

• Neuroimmunology crossovers (e.g., multiple sclerosis, NMO, paraneoplastic syndromes)
• Infectious immunology and its role in autoimmune CNS conditions
• Cytokine signaling, immune checkpoint modulation, and immune cell phenotyping with potential relevance to CNS tumors or neuroinflammation

A solid mid-tier journal in the immunology landscape. It is particularly strong in exploring the interface between chronic infection and autoimmunity, but occasionally lacks the mechanistic rigor or clinical breakthrough expected in higher-impact journals. Best used for hypothesis generation and translational insight, not definitive clinical guidance.

*Clinical Immunology is where immune theories go to gain credibility — not necessarily to be proven.*